Fingerprint
Dive into the research topics of 'Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically